Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum?

Gynecologic Oncology

Volumn 107, Issue 2, 2007, Pages 223-230

  Jordan, Susan J ^a,b   Green, Adèle C ^a   Whiteman, David C ^a   Webb, Penelope M ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Benign tumour; Borderline tumour; Mucinous ovarian cancer; Risk factor

Indexed keywords

CONTRACEPTIVE AGENT;

ADENOMA; ARTICLE; AUSTRALIA; BENIGN TUMOR; BREAST FEEDING; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CANCER; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING CESSATION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AUSTRALIA; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HEALTH STATUS; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 35348924512     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.06.006     Document Type: Article

References (33)

1. Risch H., Marrett L., Jain M., and Howe G. Differences in risk factors for epithelial ovarian cancer by histologic type. results of a case-control study. Am. J. Epidemiol. 144 4 (1996) 363-372
2. Purdie D., Webb P.M., Siskind V., Bain C., and Green A. The different etiologies of mucinous and non-mucinous epithelial ovarian cancers. Gynecol. Oncol. 88 1 Pt 2 (2003) s145-s148
3. Jordan S.J., Whiteman D.C., Purdie D.M., Green A.C., and Webb P.M. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol. Oncol. 103 3 (2006) 1122-1129
4. Pal T., Permuth-Wey J., Betts J.A., Krischer J.P., Fiorica J., Arango H., et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104 12 (2005) 2807-2816
5. Bell D.A. Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18 Suppl. 2 (2005) S19-S32
6. Scott M., and McCluggage W.G. Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data. Histol. Histopathol. 21 1 (2006) 81-92
7. Jordan S., Green A., and Webb P. Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk?. Cancer Causes Control 17 5 (2006) 623-632
8. Dal Maso L., Canzonieri V., Talamini R., Franceschi S., and La Vecchia C. Origin of ovarian cancer from benign cysts. Eur. J. Can. Prev. 10 (2001) 197-199
9. Puls L., Powell D., DePriest P., Gallion H., Hunter J., Kryscio R., et al. Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol. Oncol. 47 1 (1992) 53-57
10. Scully R.E. Early denovo ovarian cancer and cancer developing in benign ovarian lesions. Int. J. Gynaecol. Obstet. 49 (1995) S9-S15 (Suppl)
11. Cuatrecasas M., Villanueva A., Matias-Guiu X., and Prat J. K-ras mutations in mucinous ovarian tumours. Cancer 79 8 (1997) 1581-1586
12. Potter J.D. Nutrition and colorectal cancer. Cancer Causes Control 7 1 (1996) 127-146
13. Smith K.J., O'Brien S.M., Smithers B.M., Gotley D.C., Webb P.M., Green A.C., et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol., Biomarkers Prev. 14 11 Pt 1 (2005) 2481-2486
14. Shaheen N.J. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 128 6 (2005) 1554-1566
15. Frost C.A., and Green A.C. Epidemiology of solar keratoses. Br. J. Dermatol. 131 4 (1994) 455-464
16. Westhoff C., Britton J., Gammon M., Wright T., and Kelsey J. Oral contraceptives and benign ovarian tumors. Am. J. Epidemiol. 152 (2000) 242-246
17. Tavassoli F.A., and Devilee P. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs (2003), IARC Press, Lyon
18. Seidman J.D., Kurman R.J., and Ronnett B.M. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am. J. Surg. Pathol. 27 7 (2003) 985-993
19. Terry P., Miller A.B., Jones J.G., and Rohan T. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur. J. Cancer 39 (2003) 1157-1164
20. Riman T., Dickman P.W., Nilsson S., Nordlinder H., Magnusson C.M., and Persson I.R. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur. J. Epidemiol. 19 11 (2004) 1011-1019
21. Kurian A.W., Balise R.R., McGuire V., and Whittemore A.S. Histologic types of epithelial ovarian cancer: have they different risk factors?. Gynecol. Oncol. 96 2 (2005) 520-530
22. Pan S.Y., Ugnat A.M., Mao Y., Wen S.W., and Johnson K.C. Association of cigarette smoking with the risk of ovarian cancer. Int. J. Cancer 111 1 (2004) 124-130
23. Hart W.R. Mucinous tumors of the ovary: a review. Int. J. Gynecol. Pathol. 24 1 (2005) 4-25
24. Jordan S.J., Green A.C., Whiteman D.C., and Webb P.M. Risk factors for benign serous and mucinous epithelial ovarian tumors. Obstet. Gynecol. 109 3 (2007) 647-654
25. WHO, Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, in WHO technical Report Series; 894. 2000, World Health Organisation: Geneva.
26. Modugno F., Ness R.B., and Wheeler J. Reproductive risk factors for epithelial ovarian cancer according to histological type and invasiveness. Ann. Epidemiol. 11 (2001) 568-574
27. Riman T., Dickman P., Nilsson S., Correia N., Nordlinder H., Magnusson C., et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am. J. Epidemiol. 156 4 (2002) 363-373
28. Tung K.H., Goodman M.T., Wu A.H., McDuffie K., Wilkens L.R., Kolonel L.N., et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am. J. Epidemiol. 158 7 (2003) 629-638
29. Mills P.K., Riordan D.G., and Cress R.D. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol. Oncol. 95 1 (2004) 215-225
30. ABS. Australian Bureau of Statistics. National Health Survey: Users' Guide, 2001 http://abs.gov.au/Ausstats/abs@.nsf/ accessed 24th July 2006. 2001 [cited 2006 24-07-06]; Available from: http://abs.gov.au/Ausstats/abs@.nsf/.
31. Morimoto L.M., Newcomb P.A., Ulrich C.M., Bostick R.M., Lais C.J., and Potter J.D. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?. Cancer Epidemiol., Biomarkers Prev. 11 10 Pt 1 (2002) 1012-1018
32. Berger D.H., Chang H., Wood M., Huang L., Heath C.W., Lehman T., et al. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status. Cancer 85 2 (1999) 326-327
33. Garrett A.P., Lee K.R., Colitti C.R., Muto M.G., Berkowitz R.S., and Mok S.C. K-ras mutations may be an early event in mucinous ovarian tumorigenesis. Int. J. Gynecol. Pathol. 20 (2001) 244-251